Japan Family to Sue Government Over Tamiflu (Japan)
This article was originally published in PharmAsia News
The family of a teenage boy who took Tamiflu in February 2004, and then displayed abnormal behavior and died, plans to file a lawsuit against Japan's Pharmaceuticals and Medical Devices Agency. The agency determined that the boy's death did not result from Tamiflu, though the boy ran from the house barefoot and subsequently was hit by a truck while taking the drug. The father says that the lawsuit simply will help the family reach closure on what happened to their son. "We would like to know the truth about whether or not there was a causal relationship between Tamiflu and his abnormal behavior," says the father. The family is seeking 1 million yen (or $8,300). (Click here for more
You may also be interested in...
Royal Philips will make 43,000 medical ventilators by year-end for use in the US and make 2,500 more for the Strategic National Stockpile in a deal with the US government worth $646.7m. See what Philips’ CEO Frans van Houten said about it here.
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.